Primary Site >> Colorectal Cancer
Gene >> CCNG2
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. PMID: 15067352 |
Ref: Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. PMID: 18776587 |
Ref: Impact of cell-proliferation-associated gene expression on 2-deoxy-2-[(18)f]fluoro-D-glucose (FDG) kinetics as measured by dynamic positron emission tomography (dPET) in colorectal tumors. PMID: 21153447 Ref: Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53. PMID: 21348775 |
Ref: Hydroxytyrosyl ethyl ether exhibits stronger intestinal anticarcinogenic potency and effects on transcript profiles compared to hydroxytyrosol. PMID: 23411228 Ref: Anticancer activity of olive oil hydroxytyrosyl acetate in human adenocarcinoma Caco-2 cells. PMID: 23452288 |
Ref: CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance. PMID: 24307622 |
Ref: MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction. PMID: 26573378 |
Ref: Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR135A1/CCNG2 signaling pathway. PMID: 30106441 |